Main approaches to treatment of hypoxia in acute respiratory distress syndrome, bacterial and viral pneumonia (part II)

Abstract

The paper summarizes data on modern approaches to the diagnosis, prevention and treatment of severe acute parenchymal respiratory failure of various origins, including ARDS due to bacterial viral pneumonia. The work is based on the data of modern well-organized studies, analysis of international clinical guidelines with a high degree of evidence, as well as the results of our own long-term experimental studies and clinical observations of the treatment of patients with ARDS of various origins, including viral pneumonia of 2009, 2016, 2020. Scientifically grounded algorithms for prevention, differential diagnosis and personalized therapy of severe acute respiratory failure using innovative medical technologies and a wide range of respiratory and adjuvant treatment methods have been formulated. The authors tried to adapt as much as possible the existing current recommendations for the daily clinical practice of anesthesiologists and resuscitators.

The Role of Ribonucleases in the Immunopathogenesis of Experimental Acute Respiratory Distress Syndrome

“…Разработанные модели используются для внедрения новых подходов к лечению и обновления существующих рекомендаций. В настоящее время в литературе представлены многочисленные клинические исследования, которые были посвящены изучению клинической картины, течения и прогноза ОРДС [2,3]. В то же время, несмотря на многочисленные рекомендации по лечению данного заболевания, до сих пор не существует единого мнения о том, какая терапия наиболее эффективна.…”